Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sahar Al Shabasy

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
BMJ Open|December 24, 2021
EQ-VT protocol: one-size-fits-all? Challenges and innovative adaptations used in Egypt: a cross-sectional studySahar Al Shabasy, Maggie Abbassi, Samar Farid
The Patient|February 14, 2022
Determinants of Health Preferences Using Data from the Egyptian EQ-5D-5L Valuation StudySahar Al Shabasy, Fatima Al Sayah, Maggie Abbassi, et al.
Pharmacoeconomics|November 26, 2022
The Egyptian EQ-5D-5L Extensive Pilot Study: Lessons LearnedSahar Al Shabasy, Bram Roudijk, Maggie Abbassi, et al.
Pharmacoeconomics|November 17, 2021
The EQ-5D-5L Valuation Study in EgyptSahar Al Shabasy, Maggie Abbassi, Aureliano Finch, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
BMJ Open|December 24, 2021
EQ-VT protocol: one-size-fits-all? Challenges and innovative adaptations used in Egypt: a cross-sectional studySahar Al Shabasy, Maggie Abbassi, Samar Farid
The Patient|February 14, 2022
Determinants of Health Preferences Using Data from the Egyptian EQ-5D-5L Valuation StudySahar Al Shabasy, Fatima Al Sayah, Maggie Abbassi, et al.
Pharmacoeconomics|November 26, 2022
The Egyptian EQ-5D-5L Extensive Pilot Study: Lessons LearnedSahar Al Shabasy, Bram Roudijk, Maggie Abbassi, et al.
Pharmacoeconomics|November 17, 2021
The EQ-5D-5L Valuation Study in EgyptSahar Al Shabasy, Maggie Abbassi, Aureliano Finch, et al.
Pageof 1